Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH

• Status: Recruiting
• Trial end date: 2023-07-01

Summary

Chidamide combines with VP-16 and methylprednisolone in HLH

• Phase: N/A

Details

• Lead Sponsor: Beijing Friendship Hospital
• Treatments: Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate